CATALOGO DEI PRODOTTI DELLA RICERCA

MASOLA, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.126
EU - Europa 1.976
AS - Asia 1.314
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 28
OC - Oceania 2
Totale 5.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.084
RU - Federazione Russa 771
SG - Singapore 528
GB - Regno Unito 409
CN - Cina 386
IT - Italia 222
BR - Brasile 138
SE - Svezia 127
VN - Vietnam 126
FR - Francia 117
HK - Hong Kong 99
IE - Irlanda 87
FI - Finlandia 82
DE - Germania 80
KR - Corea 41
BD - Bangladesh 25
AR - Argentina 23
UA - Ucraina 23
IN - India 21
ID - Indonesia 18
CA - Canada 16
BE - Belgio 13
AT - Austria 11
MX - Messico 10
TR - Turchia 10
ZA - Sudafrica 9
IL - Israele 7
NG - Nigeria 7
JP - Giappone 6
CH - Svizzera 5
EC - Ecuador 5
ES - Italia 5
IQ - Iraq 5
RO - Romania 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
MA - Marocco 4
PK - Pakistan 4
PL - Polonia 4
PS - Palestinian Territory 4
CL - Cile 3
HN - Honduras 3
LB - Libano 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
GE - Georgia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
NI - Nicaragua 2
NL - Olanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
NE - Niger 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.629
Salva come PNG Salva come JPEG
Città #
Southend 355
Moscow 274
Singapore 272
Chandler 271
Ashburn 240
San Jose 174
Jacksonville 137
Woodbridge 130
Dallas 113
Hong Kong 97
Ann Arbor 96
Beijing 85
Dublin 85
Council Bluffs 80
The Dalles 55
Verona 55
Houston 47
New York 41
Wilmington 41
Lawrence 37
Princeton 37
Ho Chi Minh City 29
Los Angeles 29
Nanjing 22
Columbus 21
Redondo Beach 21
Dong Ket 20
Shenyang 20
Helsinki 19
Jinan 19
Hanoi 18
Redmond 17
Buffalo 16
Santa Clara 16
São Paulo 16
Munich 14
Brussels 13
Tianjin 13
Milan 12
Chicago 11
Jakarta 11
Seattle 11
Hebei 10
Orem 10
Vienna 10
Boardman 9
Taizhou 9
Brooklyn 8
Denver 8
Guangzhou 8
Jiaxing 8
Ningbo 8
Rome 8
Frankfurt am Main 7
Johannesburg 7
Nanchang 7
Padova 7
Phoenix 7
Montreal 6
San Francisco 6
Shanghai 6
Stockholm 6
Tokyo 6
Turku 6
Zhengzhou 6
Abuja 5
Chennai 5
Da Nang 5
Fairfield 5
Hangzhou 5
Istanbul 5
Sindelfingen 5
Toronto 5
Atlanta 4
Auburn Hills 4
Barnet 4
Catanzaro 4
Changsha 4
Genova 4
Hải Dương 4
Kochi 4
Lancaster 4
London 4
Norwalk 4
Querétaro 4
Quito 4
Rio de Janeiro 4
Seoul 4
Warsaw 4
Baltimore 3
Biên Hòa 3
Bologna 3
Buenos Aires 3
Cabo Frio 3
Campinas 3
Conselheiro Lafaiete 3
Detroit 3
Florence 3
Fuzhou 3
Governador Valadares 3
Totale 3.400
Salva come PNG Salva come JPEG
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 261
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 259
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 203
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 188
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 187
mTOR inhibitors and renal allograft: Yin and Yang. 186
Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats. 184
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 184
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 182
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 181
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 172
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 171
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 165
Sulodexide and glycosaminoglycans in the progression of renal disease. 164
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 164
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 164
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 154
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 151
Heparanase as a target in cancer therapy. 150
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 149
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 148
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 148
Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells 147
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells. 146
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 146
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 140
Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion 139
Heparanase: another renal player controlled by vitamin d. 139
L: -citrulline Prevents Alveolar and Vascular Derangement in a Rat Model of Moderate Hyperoxia-induced Lung Injury. 132
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 132
Endothelial Glycocalyx as a Regulator of Fibrotic Processes 119
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. 111
LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase 108
The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells 96
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. 96
Impact of heparanase on renal fibrosis. 86
Role of Heparanase in Tumor Progression: Molecular Aspects and Therapeutic Options 74
Totale 5.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.394
article - articoli 18.664
book - libri 0
conference - conferenze 730
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022254 0 48 4 54 4 9 10 22 7 8 17 71
2022/2023673 51 92 65 103 64 137 15 39 80 4 16 7
2023/2024255 16 25 25 12 32 42 9 19 1 17 45 12
2024/2025740 45 43 30 131 33 30 47 35 118 30 67 131
2025/20262.244 162 95 110 372 619 163 218 121 130 153 35 66
2026/202783 35 48 0 0 0 0 0 0 0 0 0 0
Totale 5.726